Status
Conditions
Treatments
About
This study is trying to answer the following research question: "Are there any differences between effects of aerobic training and myofascial release on claudication among peripheral arterial insuffiency patients?
Full description
Peripheral arterial disease is a systemic disorder and for the most part progressive. The condition is associated with life and limb-threatening complications. Symptoms of PAD range from intermittent claudication-defined as fatigue or discomfort in calf, buttock, or thigh muscles on exertion that is relieved by rest-to critical limb ischemia-defined as distal leg pain at rest with or without ischemic ulcers Despite many advances in endovascular surgery, amputations of digits and limbs are not uncommon. Thus, the present-day approach is to prevent the disorder in the first place. There are many evidences that support changes in lifestyle can significantly decrease the rate of progression of the disease and improve the quality of life in addition to aerobic training exercise and manual therapy .
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:The patients had been met the following criteria to be involved in this study:
Patients from both sexes who were medically diagnosed as peripheral arterial insufficiency with type II claudication at single lower limb 2- Peripheral arterial insufficiency patients, who have ABI inbetween0.90-0.50
Age was ranged from 45 -55years.
Patients who have intermittent claudicating pain during activities not at rest.
BMI between 25-29.9 kg
Exclusion Criteria:
patients who was not willing to participate in the study.
patients who have severe foot ulcer, and who were diagnosed as Peripheral arterial insufficiency grade III, IV.
patients who have the ABI is less than 0.50
Patients who have past history of (unstable cardiovascular diseases, marked dyspnea on exertion or with chronic obstructive pulmonary diseases (COPD), liver and kidney diseases).
Primary purpose
Allocation
Interventional model
Masking
40 participants in 2 patient groups
Loading...
Central trial contact
farag abdel-moniem ali, professor; ola elgohary
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal